Alexandria Real Estate Equities (NYSE:ARE) Releases FY 2025 Earnings Guidance

Alexandria Real Estate Equities (NYSE:ARE) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 9.230-9.430 for the period, compared to the consensus earnings per share estimate of 9.470. The company issued revenue guidance of -.

Alexandria Real Estate Equities Stock Up 0.4 %

Shares of NYSE ARE opened at $102.03 on Tuesday. The stock has a market capitalization of $17.83 billion, a P/E ratio of 62.21, a PEG ratio of 3.85 and a beta of 1.16. The stock’s fifty day moving average is $102.13 and its 200 day moving average is $112.23. Alexandria Real Estate Equities has a 52 week low of $94.35 and a 52 week high of $130.14. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.20 and a current ratio of 0.20.

Alexandria Real Estate Equities (NYSE:ARE) last posted its earnings results on Monday, January 27th. The real estate investment trust reported $2.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $1.48. Alexandria Real Estate Equities had a net margin of 9.62% and a return on equity of 1.31%. Sell-side analysts forecast that Alexandria Real Estate Equities will post 9.47 earnings per share for the current fiscal year.

Alexandria Real Estate Equities Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st were paid a $1.32 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This is a positive change from Alexandria Real Estate Equities’s previous quarterly dividend of $1.30. This represents a $5.28 annualized dividend and a yield of 5.18%. Alexandria Real Estate Equities’s payout ratio is 321.95%.

Alexandria Real Estate Equities announced that its Board of Directors has approved a stock repurchase program on Monday, December 9th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the real estate investment trust to buy up to 2.7% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

ARE has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft downgraded shares of Alexandria Real Estate Equities from a “buy” rating to a “hold” rating and dropped their target price for the company from $135.00 to $112.00 in a research report on Friday, November 15th. Evercore ISI dropped their price target on shares of Alexandria Real Estate Equities from $129.00 to $124.00 and set an “in-line” rating on the stock in a research report on Wednesday, October 23rd. Wedbush reissued an “outperform” rating and set a $110.00 price objective (down from $120.00) on shares of Alexandria Real Estate Equities in a report on Friday, December 6th. JPMorgan Chase & Co. lowered Alexandria Real Estate Equities from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $133.00 to $121.00 in a report on Wednesday, November 27th. Finally, JMP Securities decreased their price target on Alexandria Real Estate Equities from $140.00 to $130.00 and set a “market outperform” rating for the company in a report on Friday, November 15th. Nine research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $121.90.

Alexandria Real Estate Equities Company Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle.